Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-8-9
pubmed:abstractText
Because elevated blood pressure is one of the defining criteria of the metabolic syndrome, treatment of hypertension will be required in many, if not most, children and adolescents diagnosed with the metabolic syndrome. This review highlights several aspects of the approach to treatment of hypertension in young patients with the metabolic syndrome, including the definition of hypertension, use of nonpharmacologic measures, indications for instituting antihypertensive medications, and the potential adjunctive role that insulin-sensitizing agents may play in blood pressure reduction. The choice of antihypertensive agent is also discussed, along with consideration of the diabetogenic effects of various classes of antihypertensive agents. Consideration of all of these issues is important in achieving blood pressure control in children and adolescents with the metabolic syndrome, as appropriate treatment may help to forestall the development not only of type 2 diabetes but also of the cardiovascular disease that is frequently already present at the time of diagnosis of type 2 diabetes in adults.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1559-4564
pubmed:author
pubmed:issnType
Print
pubmed:volume
1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
259-68
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:17679805-Adolescent, pubmed-meshheading:17679805-Antihypertensive Agents, pubmed-meshheading:17679805-Blood Pressure, pubmed-meshheading:17679805-Cardiovascular Diseases, pubmed-meshheading:17679805-Child, pubmed-meshheading:17679805-Child, Preschool, pubmed-meshheading:17679805-Diabetes Mellitus, Type 2, pubmed-meshheading:17679805-Diet, pubmed-meshheading:17679805-Exercise, pubmed-meshheading:17679805-Humans, pubmed-meshheading:17679805-Hypertension, pubmed-meshheading:17679805-Hypoglycemic Agents, pubmed-meshheading:17679805-Infant, pubmed-meshheading:17679805-Life Style, pubmed-meshheading:17679805-Metabolic Syndrome X, pubmed-meshheading:17679805-Patient Selection, pubmed-meshheading:17679805-Practice Guidelines as Topic, pubmed-meshheading:17679805-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
Management of hypertension in children and adolescents with the metabolic syndrome.
pubmed:affiliation
Division of Pediatric Endocrinology, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY 10467, USA.
pubmed:publicationType
Journal Article, Review